TherapeuticsMD (TXMD) Short Interest Ratio & Short Volume $1.46 0.00 (0.00%) As of 04:00 PM Eastern Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock TherapeuticsMD Short Interest DataTherapeuticsMD (TXMD) has a short interest of 146,500 shares, representing 1.29% of the float (the number of shares available for trading by the public). This marks a -13.42% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.5, indicating that it would take 0.5 days of the average trading volume of 155,256 shares to cover all short positions.Current Short Interest146,500 sharesPrevious Short Interest169,200 sharesChange Vs. Previous Month-13.42%Dollar Volume Sold Short$152,360.00Short Interest Ratio0.5 Days to CoverLast Record DateApril 15, 2025Outstanding Shares11,574,000 sharesFloat Size11,340,000 sharesShort Percent of Float1.29%Today's Trading Volume7,311 sharesAverage Trading Volume155,256 sharesToday's Volume Vs. Average5% Short Selling TherapeuticsMD? Sign up to receive the latest short interest report for TherapeuticsMD and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartTXMD Short Interest Over TimeTXMD Days to Cover Over TimeTXMD Percentage of Float Shorted Over Time TherapeuticsMD Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/2025146,500 shares $152,360.00 -13.4%1.3%0.5 $1.04 3/31/2025169,200 shares $157,356.00 -0.6%1.5%0.6 $0.93 3/15/2025170,200 shares $123,429.04 -19.1%1.5%0.3 $0.73 2/28/2025210,500 shares $195,765.00 +35.1%1.9%0.4 $0.93 2/15/2025155,800 shares $160,474.00 -10.4%1.4%0.3 $1.03 1/31/2025173,800 shares $187,704.00 -27.6%1.5%0.6 $1.08 1/15/2025240,200 shares $266,622.00 +1,901.7%2.1%0.8 $1.11 12/31/202412,000 shares $10,320.00 -43.7%0.1%0 $0.86 12/15/202421,300 shares $25,986.00 +1.0%0.2%1.1 $1.22 11/30/202421,100 shares $29,962.00 -29.9%0.2%1.3 $1.42 Get the Latest News and Ratings for TXMD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for TherapeuticsMD and its competitors with MarketBeat's FREE daily newsletter. 11/15/202430,100 shares $42,140.00 +1.4%0.3%1.9 $1.40 10/31/202429,700 shares $46,035.00 +26.4%0.3%2.2 $1.55 10/15/202423,500 shares $35,893.90 -6.4%0.2%1.7 $1.53 9/30/202425,100 shares $41,666.00 -72.5%0.2%1.8 $1.66 9/15/202491,300 shares $163,417.87 -8.4%0.8%5.7 $1.79 8/31/202499,700 shares $187,934.50 -12.1%0.9%5.9 $1.89 8/15/2024113,400 shares $182,574.00 +172.6%1.0%6.6 $1.61 7/31/202441,600 shares $72,800.00 -2.4%0.4%2.6 $1.75 7/15/202442,600 shares $77,106.00 -19.6%0.4%2.6 $1.81 6/30/202453,000 shares $85,330.00 +57.7%0.5%2.7 $1.61 6/15/202433,600 shares $68,208.00 -7.7%0.3%1.8 $2.03 5/31/202436,400 shares $80,808.00 -7.4%0.3%1.9 $2.22 5/15/202439,300 shares $82,137.00 -23.2%0.4%1.7 $2.09 4/30/202451,200 shares $96,256.00 +11.6%0.5%2.3 $1.88 4/15/202445,900 shares $89,505.00 +1.6%0.4%2 $1.95 3/31/202445,200 shares $103,508.00 -4.6%0.4%2.1 $2.29 3/15/202447,400 shares $113,760.00 +15.9%0.5%2.4 $2.40 2/29/202440,900 shares $98,160.00 -18.9%0.4%1.8 $2.40 2/15/202450,400 shares $112,896.00 -8.2%0.5%2.6 $2.24 1/31/202454,900 shares $124,074.00 -57.7%0.5%2.5 $2.26 1/15/2024129,800 shares $295,944.00 -39.8%1.3%5.6 $2.28 12/31/2023215,600 shares $485,100.00 +143.1%N/A9.3 $2.25 12/15/202388,700 shares $207,558.00 -56.8%0.9%3.9 $2.34 11/30/2023205,400 shares $529,932.00 -4.1%2.0%9.4 $2.58 11/15/2023214,100 shares $505,276.00 -13.8%2.1%10.7 $2.36 10/31/2023248,500 shares $529,305.00 +162.4%2.4%13.1 $2.13 10/15/202394,700 shares $240,538.00 -8.7%0.9%4.8 $2.54 9/30/2023103,700 shares $313,174.00 -71.9%1.1%5.4 $3.02 9/15/2023369,000 shares $1.23 million +21.3%3.8%18.2 $3.33 8/31/2023304,300 shares $1.15 million -5.1%3.1%13.2 $3.79Trump’s Bitcoin Reserve is No Accident… (Ad)Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new blockchain development…Just click here to get all the details on this crypto coin now 8/15/2023320,700 shares $1.23 million -4.7%3.3%13.1 $3.84 7/31/2023336,400 shares $1.37 million -7.9%3.6%11.4 $4.06 7/15/2023365,100 shares $1.43 million +0.3%3.9%11.1 $3.93 6/30/2023364,200 shares $1.50 million +21.4%3.9%10.2 $4.12 6/15/2023300,100 shares $1.15 million +1.7%3.2%8 $3.84 5/31/2023295,100 shares $1.22 million -5.6%3.1%7.8 $4.15 5/15/2023312,600 shares $1.37 million -8.7%3.3%8.1 $4.39 4/30/2023342,400 shares $1.21 million +3.5%3.7%10 $3.54 4/15/2023330,900 shares $1.20 million +4.3%3.6%8.8 $3.62 3/31/2023317,200 shares $1.19 million +20.2%3.4%8 $3.75 3/15/2023263,800 shares $962,870.00 +10.4%3.0%5.5 $3.65 2/28/2023239,000 shares $1.19 million -11.2%2.7%1.9 $4.96 2/15/2023269,000 shares $1.38 million -5.4%3.2%2.1 $5.13 1/31/2023284,400 shares $1.50 million -12.1%3.2%2.1 $5.27 1/15/2023323,500 shares $1.75 million -4.1%3.8%2.4 $5.40 12/30/2022337,200 shares $1.88 million -26.2%4.0%2.5 $5.59 12/15/2022457,000 shares $3.03 million +46.8%5.4%3.4 $6.63 11/30/2022311,300 shares $1.43 million -19.5%3.7%2.4 $4.58 11/15/2022386,500 shares $2.29 million +12.9%4.6%5.4 $5.93 10/31/2022342,400 shares $2.17 million +2.4%4.1%2.7 $6.33 10/15/2022334,400 shares $2.15 million -3.3%4.0%1.2 $6.44 9/30/2022345,900 shares $2.30 million -5.9%4.2%0.8 $6.64 9/15/2022367,600 shares $2.87 million -11.2%4.4%0.6 $7.80 8/31/2022413,800 shares $4.10 million -33.3%5.0%0.5 $9.91 8/15/2022620,700 shares $5.74 million -32.6%8.0%0.6 $9.24 7/31/2022921,100 shares $5.74 million +38.6%11.9%0.6 $6.23 7/15/2022664,500 shares $3.95 million +65.7%8.6%0.5 $5.94 6/30/2022401,000 shares $3.99 million -28.3%5.2%0.3 $9.95 6/15/2022559,600 shares $5.55 million -72.2%7.4%0.5 $9.92 5/31/20222,010,000 shares $19.96 million +36.7%26.4%2.2 $9.93 5/15/20221,470,000 shares $4.51 million +94.1%19.3%2.2 $3.07 4/30/2022757,300 shares $7.64 million -97.6%10.0%4.3 $10.09 4/15/202231,900,000 shares $9.25 million +2.8%8.4%4.5 $0.29 3/31/202231,030,000 shares $11.79 million -2.6%8.2%4.7 $0.38 3/15/202231,870,000 shares $10.37 million +28.6%N/A4.1 $0.33 2/28/202224,790,000 shares $5.93 million -2.4%N/A3.3 $0.24 2/15/202225,410,000 shares $6.68 million +11.6%N/A3.8 $0.26 1/31/202222,760,000 shares $6.92 million -10.2%N/A3.4 $0.30 1/15/202225,350,000 shares $8.75 million +35.2%N/A4.1 $0.35 12/31/202118,750,000 shares $6.67 million -29.4%N/A3.2 $0.36 12/15/202126,550,000 shares $10.78 million -20.0%N/A5.7 $0.41 11/30/202133,180,000 shares $16.42 million +9.9%N/A6.9 $0.50 11/15/202130,180,000 shares $18.50 million +3.6%N/A7 $0.61 10/29/202129,130,000 shares $21.21 million +2.5%N/A6.3 $0.73 10/15/202128,430,000 shares $20.49 million -1.6%N/A5.7 $0.72 9/30/202128,890,000 shares $21.42 million +0.7%N/A5.6 $0.74 9/15/202128,680,000 shares $20.74 million +24.4%N/A4.8 $0.72 8/31/202123,060,000 shares $18.33 million +2.1%5.9%4.1 $0.80 8/13/202122,580,000 shares $19.45 million -30.2%N/A4 $0.86 7/30/202132,340,000 shares $32.34 million -4.9%N/A5.9 $1.00Trump’s Bitcoin Reserve is No Accident… (Ad)Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new blockchain development…Just click here to get all the details on this crypto coin now 7/15/202134,000,000 shares $35.02 million -39.3%9.3%5.4 $1.03 6/30/202156,000,000 shares $66.64 million -1.1%15.3%8 $1.19 6/15/202156,620,000 shares $71.34 million -5.1%15.4%8 $1.26 5/28/202159,670,000 shares $72.20 million -3.8%16.3%7 $1.21 5/14/202162,040,000 shares $65.76 million -4.1%N/A5.9 $1.06 4/30/202164,690,000 shares $72.45 million +0.0%N/A4.4 $1.12 4/15/202164,670,000 shares $78.90 million +8.3%N/A4.2 $1.22 3/31/202159,720,000 shares $80.02 million +3.7%N/A4 $1.34 3/15/202157,570,000 shares $91.54 million +3.3%N/A4 $1.59 2/26/202155,740,000 shares $85.84 million -23.3%N/A4.2 $1.54 2/12/202172,670,000 shares $139.53 million +11.0%N/A6.5 $1.92 1/29/202165,500,000 shares $104.15 million -0.8%N/A8.1 $1.59 1/15/202166,050,000 shares $95.11 million -14.1%N/A11.9 $1.44 12/31/202076,900,000 shares $92.28 million -2.9%N/A16.8 $1.20 12/15/202079,220,000 shares $91.10 million -4.4%N/A19.2 $1.15 11/30/202082,850,000 shares $113.50 million +0.3%N/A24.5 $1.37 11/15/202082,630,000 shares $101.63 million -0.8%N/A27.7 $1.23 10/30/202083,290,000 shares $109.94 million -2.0%34.9%31.4 $1.32 10/15/202085,000,000 shares $136 million -0.9%35.7%28.9 $1.60 9/30/202085,730,000 shares $135.45 million -1.1%36.0%22.7 $1.58 9/15/202086,680,000 shares $116.15 million -2.2%36.4%21.5 $1.34 8/31/202088,660,000 shares $129.44 million -0.3%37.2%19.8 $1.46 8/14/202088,910,000 shares $148.48 million +4.1%37.4%17.3 $1.67 7/31/202085,450,000 shares $158.08 million +3.0%35.9%15.8 $1.85 7/15/202082,960,000 shares $123.61 million +0.1%34.9%13.9 $1.49 6/30/202082,860,000 shares $103.58 million -0.2%34.9%14.8 $1.25 6/15/202082,990,000 shares $108.72 million +0.8%35.0%15.3 $1.31 5/29/202082,340,000 shares $93.04 million +0.4%34.7%15.3 $1.13 5/15/202082,020,000 shares $95.96 million +0.7%34.5%16.3 $1.17 TXMD Short Interest - Frequently Asked Questions What is TherapeuticsMD's current short interest? Short interest is the volume of TherapeuticsMD shares that have been sold short but have not yet been covered or closed out. As of April 15th, traders have sold 146,500 shares of TXMD short. 1.29% of TherapeuticsMD's shares are currently sold short. Learn More on TherapeuticsMD's current short interest. Which institutional investors are shorting TherapeuticsMD? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of TherapeuticsMD: Simplex Trading LLC, Group One Trading LLC, Citadel Advisors LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for TherapeuticsMD? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.29% of TherapeuticsMD's floating shares are currently sold short. Is TherapeuticsMD's short interest increasing or decreasing? TherapeuticsMD saw a decline in short interest during the month of April. As of April 15th, there was short interest totaling 146,500 shares, a decline of 13.4% from the previous total of 169,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is TherapeuticsMD's float size? TherapeuticsMD currently has issued a total of 11,574,000 shares. Some of TherapeuticsMD's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. TherapeuticsMD currently has a public float of 11,340,000 shares. How does TherapeuticsMD's short interest compare to its competitors? 1.29% of TherapeuticsMD's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to TherapeuticsMD: Biomea Fusion, Inc. (30.40%), Applied Therapeutics, Inc. (14.88%), Cabaletta Bio, Inc. (13.85%), Vistagen Therapeutics, Inc. (1.98%), Milestone Pharmaceuticals Inc. (4.93%), Acumen Pharmaceuticals, Inc. (3.95%), Skye Bioscience, Inc. (14.88%), Alto Neuroscience, Inc. (14.10%), Achilles Therapeutics plc (1.26%), Assertio Holdings, Inc. (5.81%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.71 billion), iShares 20+ Year Treasury Bond ETF ($9.48 billion), Strategy Incorporated ($8.92 billion), Charter Communications, Inc. ($3.86 billion), Apollo Global Management, Inc. ($3.86 billion), Capital One Financial Co. ($3.72 billion), Super Micro Computer, Inc. ($3.47 billion), AppLovin Co. ($2.64 billion), VanEck Semiconductor ETF ($2.46 billion), and The Kroger Co. ($2.33 billion). View all of the most shorted stocks. What does it mean to sell short TherapeuticsMD stock? Short selling TXMD is an investing strategy that aims to generate trading profit from TherapeuticsMD as its price is falling. TXMD shares are trading down $0.06 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against TherapeuticsMD? A short squeeze for TherapeuticsMD occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of TXMD, which in turn drives the price of the stock up even further. How often is TherapeuticsMD's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TXMD, twice per month. The most recent reporting period available is April, 15 2025. More Short Interest Resources from MarketBeat Related Companies Biomea Fusion Short Interest Applied Therapeutics Short Interest Cabaletta Bio Short Interest Vistagen Therapeutics Short Interest Milestone Pharmaceuticals Short Interest Acumen Pharmaceuticals Short Interest Skye Bioscience Short Interest Alto Neuroscience Short Interest Achilles Therapeutics Short Interest Assertio Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:TXMD) was last updated on 5/15/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredSilver Demand Is Soaring-Supply Can't Keep UpSilver demand hit 1.16 billion ounces in 2024-while supply fell short again for the fourth year in a row. I...i2i Marketing Group, LLC | SponsoredShocking AI play that’s beats Nvidia by a country mileYou’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredTrump’s Bitcoin Reserve is No Accident…Bitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TherapeuticsMD, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TherapeuticsMD With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy TXMD Stock Free TXMD Stock Alerts